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EDITORIAL
Positioning coronary multislice computed
tomography as a pertinent tool for cardiac
exploration
Positionner le scanner coronaire comme un examen cardiaque pertinentKEYWORDS
MSCT;
Coronary;
A major advance took place 10 years ago in the diagnosis of heart disease: multislice
computed tomography (MSCT) using retrospective electrocardiogram (ECG) gating was able
to image the coronary tree [1]. For the ﬁrst time, cardiologists could use a non-invasive
method to assess coronary stenosis and atheroma. The role of MSCT in routine clinicalCardiomyopathy
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practice has now to be deﬁned [2—4].
The diagnostic and predictive value of bicycle or treadmill ECG tests, stress imaging and
invasive coronary angiography are documented by a large body of evidence, and their use in
guiding patient management is well established and codiﬁed in clinical guidelines [5,6]. The
use of computed tomography (CT) versus angiography has been widely evaluated, initially
with small studies involving highly specialized teams, and more recently in a multicentre
evaluation [7] and a meta-analysis [8]. At ﬁrst, exploration using coronary CT appeared
unsuitable for all cases. Regular and low sinus rhythm is necessary, patients must be able
to tolerate a 6 to 10-second episode of apnoea and an experienced team is needed to
perform the test.
Non-obstructive coronary atheroma can be responsible for the development of acute
coronary syndromes. This condition is assessable with MSCT, unlike stress tests or, in certain
cases, conventional coronary angiography [9]. The prognostic value — the major concern
for patient care — of MSCT has also been evaluated successfully in small studies [10,11]. In
contrast to stress tests that identify only two groups (subjects with or without obstructive
atheroma), coronary MSCT further identiﬁes a third group: subjects with non-obstructive
atheroma. New challenges will emerge regarding medical treatment as this newly identi-
ﬁed group has a poorer prognosis than patients without coronary atheroma [10]. Should we,
for example, consider patients with non-obstructive atheroma for primary or secondary
prevention?
Recent technical evolutions offer new perspectives: acquisition of the entire heart in
one beat with approximately 1mSv radiation exposure may extend the use of coronary CT
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nd may broaden the ﬁeld of indications. This very low dose,
quivalent to the natural irradiation dose received during a
-month stay in Brittany is no longer an issue, and has to be
ompared with the 10—15mSv current exposure emitted for
oronary CT.
The current status of cardiac CT means that it is unlikely
o replace any of the cardiac exploration methods in use
oday. Diagnostic tests are valuable only if they lead to a
reatment associated with better clinical outcomes; to date
oronary CT has not been proven to have a direct effect on
linical outcomes.
The presence of calciﬁcation, a major component of
theroma, compromises stenosis assessment. In a recent
ulticentre study, 22% of the original cohort were exclued
ecause they had an Agaggston calcium score greater than
00 [7]. Moreover, CT performance was logically compared
ith angiography alone, with a cut-off value of 50% steno-
is. This measure, when considered alone, is of little value
n the decision to perform revascularization, which has to be
unctionally driven. Documentation of ischaemia is still nec-
ssary before considering revasularization, and stress tests
re warranted after the identiﬁcation of greater than 50%
tenosis. CT scanning will not replace conventional angiog-
aphy, not only because the latter has a better spatial and
emporal resolution, but also because most of the revas-
ularization can be performed during the same diagnostic
rocedure.
The indications for CT angiography depend on the perfor-
ance of the CT scan or on other explorations in the deﬁned
linical condition (left bundle branch block [LBBB], inabillity
o perform a stress test, inconclusive test) and the pretest
robability of coronary disease. Most of the available accu-
acy data concerning the detection of coronary stenoses by
T angiography have been obtained in patients with sus-
ected coronary artery disease and stable symptoms. The
onsistently high negative predictive value (NPV) in all of
hese studies suggests that CT angiography will be clinically
seful to rule out coronary stenoses in this patient group.
n patients with a very high pretest likelihood of disease,
he use of CT angiography will most likely not result in a
negative’ scan that would help avoid invasive angiography.
herefore, the use of CT angiography should be restricted to
atients with an intermediate pretest likelihood of coronary
rtery disease.
A recent meta-analysis [8] carried out to assess the per-
ormance of 16- versus 64-slice CT showed, respectively:
5% versus 97% sensitivity (P = 0.03); 69% versus 90% speci-
city (P < 0.001); 79% versus 93% positive predictive value
PPV) (P < 0.001); 92% versus 96% NPV (P < 0.001). Sixty-four-
ection spiral CT had a signiﬁcantly higher speciﬁcity and
PV on a per-patient basis compared with 16-section CT for
he detection of greater than 50% coronary artery steno-
is. These promising results obtained from a meta-analysis
f data from specialized, single-centre studies need to be
onsidered in terms of the data from another recent multi-
entre study [7] showing a sensitivity of 85% (95% CI, 79—90),
speciﬁcity of 90% (95% CI, 83—94), a PPV of 91% (95%I, 86—95), and a NPV of 83% (95% CI, 75—89). However,
T angiography was similar to conventional angiography in
ts ability to identify patients who subsequently underwent
evascularization.
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Several studies have evaluated the accuracy of CT angiog-
aphy in speciﬁc clinical scenarios. The study by Boulmier et
l. in patients with cardiomyopathy of unknown origin [12],
ublished in this issue of Archives of Cardiovascular Dis-
ases, shows interesting results: the sensitivity, speciﬁcity,
PV and NPV for detecting coronary artery disease were
7.5, 98.5, 67.7 and 99.6%, respectively, in the per-segment
ssessment, and 100, 91, 75 and 100% in the per-patient
valuation, in accordance with other studies [13]. In the
ame study, both the coronary venous system and left-
entricular ejection fraction (LVEF) were assessable. This
one-shot exploration’ can conﬁrm LVEF dysfunction, classify
hether or not the cardiomyopathy is ischaemic, and helps
he intervention, should it be judged necessary, by consider-
ng either revascularization (in the case of diffused coronary
isease or with characteristics of total chronic occlusions or
alciﬁcations) or resynchronization.
Imaging the coronary artery in patients with heart fail-
re has several speciﬁc issues. Tachycardia is often present
nd the use of beta-blockers to lower the rhythm may
e dangerous. Injecting a bolus of contrast medium may,
y elevating LV diastolic pressure, lead to cardiac decom-
ensation; thus the exploration has to be performed in
pecialized centres in stable patients. With reduced cardiac
utput, circulation time increases, and the delay between
he injection of contrast medium and the scanning must be
djusted accordingly. Most scanners can make such adjust-
ents automatically using a bolus tracking that triggers
mage acquisition. Some physiological aspects may improve
he image quality: as cardiac output decreases image con-
rast increases because of reduced dilution of contrast
edium by blood; left-ventricular dysfunction mechanically
ecreases coronary motion speed and amplitude, result-
ng in theoretically fewer motion artifacts. However, the
mage quality may not be as good as expected, probably
ecause coronary perfusion can decrease as left-ventricular
nd-diastolic pressure increases.
LBBB was observed in 50% of the patients in the study
eported by Boulmier et al. [12]. Many issues are appar-
nt for functional non-invasive explorations in the case of
BBB. The diagnostic accuracy of stress myocardial perfu-
ion imaging and stress echocardiography in patients with
BBB can be reduced because of heart-rate dependent
eversible perfusion defects in the former and conduction-
elated abnormalities of septal motion or thickening in the
atter. The treadmill test is also uninterpretable because of
onduction abnormalities. In contrast, performance of the
T scan is not inﬂuenced by the presence of LBBB [14].
The pretest probability of coronary artery disease may
mpact on the diagnostic performance of the CT scan [4].
he speciﬁcity is lower in the high pretest probability group
ompared with the low pretest probability group, whereas
ensitivity is lower in the per-segment analysis in the low
retest probability group. This observation can probably be
xplained by the higher calcium scores in the higher prob-
bility groups, which tend to overestimate the severity of
tenosis. Because of the very high NPV, a negative CT scan
n an intermediate estimated pretest probability reduces the
stimated post-test probability almost to zero. Thus these
atients would not need to have further downstream diag-
ostic tests. In their article, Boulmier et al. report a 41%
ertin
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prevalence of coronary disease and criteria for ischaemic
heart disease in 10% of patients. Thus coronary disease has
been ruled out for more than 50% of the patients, positioning
the CT scan as a pertinent tool in this indication.
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